Not your typical chronic obstructive pulmonary disease exacerbation: Aspergillus tracheobronchitis in a nonclassical immunocompromised host

Southern Medical Journal

Volumn 103, Issue 4, 2010, Pages 361-365

  Thonar, Benjamin ^a   Yoder, Mark ^a   Cleaves, Constance ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aspergillus; Bronchoscopy; COPD; Dyspnea; Opportunistic infection

Indexed keywords

IPRATROPIUM BROMIDE; LEVOFLOXACIN; PREDNISONE; SALBUTAMOL; VANCOMYCIN;

AGED; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COUGHING; DISEASE EXACERBATION; DYSPNEA; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; HUMAN; PHYSICAL EXAMINATION; TRACHEOBRONCHITIS;

AGED; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; PULMONARY ASPERGILLOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 77953356422     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181d39008     Document Type: Article

References (15)

1. Agustí C, Rañó A, Filella, et al. Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: etiology, prognostic factors, and associated inflammatory response. Chest 2003;123:488-498.
2. Stankovic K, Sève P, Hot A, et al. Aspergillosis in systemic diseases treated with steroids and/or immunosuppressive drugs: report of 9 cases and review of the literature[in French]. Rev Med Interne 2006;27:813-827.
3. Leav BA, Fanburg B, Hadley S. Invasive pulmonary aspergillosis associated with high-dose inhaled fluticasone. N Engl J Med 2000;343: 586.
4. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007;30:782-800.
5. Samarakoon P, Soubani AO. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Respir Dis 2008;5:19-27.
6. Cornillet A, Camus C, Nimubona S, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006;43:577-584.
7. Thompson GR III, Patterson TF. Pulmonary aspergillosis. Semin Respir Crit Care Med 2008;29:103-110.
8. Jenks KA, Stamp LK, O'Donnell JL, et al. Leflunomide-associated infections in rheumatoid arthritis. J Rheumatol 2007;34:2201-2203.
9. Grover R, Dhir V, Aneja R, et al. Severe infections following leflunomide therapy for rheumatoid arthritis. Rheumatology (Oxford) 2006;45: 918-920.
10. Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying anti-rheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum 2006;54:628-634.
11. Tasci S, Glasmacher A, Lentini S, et al. Pseudomembranous and obstructive Aspergillus tracheobronchitis- optimal diagnostic strategy and outcome. Mycoses 2006;49:37-42.
12. Rañó A, Agustí C, Jimenez P, et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax 2001;56:379-387.
13. Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000;30:696-709.
14. Routsi C, Kaltsas P, Bessis E, et al. Airway obstruction and acute respiratory failure due to Aspergillus tracheobronchitis. Crit Care Med 2004;32:580-582.
15. Herbrecht R, Denning DW, Patterson TF, et al; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-415. (Pubitemid 34851833)